The Safety of Cannabis-Based Medicines for Pediatric Cancer Patients

1 min read
Source: Medpage Today
The Safety of Cannabis-Based Medicines for Pediatric Cancer Patients
Photo: Medpage Today
TL;DR Summary

A retrospective review found that the tetrahydrocannabinol (THC) dose of edible cannabis correlated with the degree of toxicity in children under 6 years old. THC ingestions of at least 1.7 mg/kg can predict severe and prolonged toxicity, suggesting that exposures exceeding this threshold should be managed in pediatric services with prolonged observation or admission capabilities. The study highlights the need for improved cannabis regulations and emphasizes the heightened risk posed by cannabis edibles in young children.

Share this article

Reading Insights

Total Reads

0

Unique Readers

1

Time Saved

4 min

vs 5 min read

Condensed

91%

86676 words

Want the full story? Read the original article

Read on Medpage Today